|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Advanced BioScience Laboratories, Inc. Awarded “NIAID Preclinical Development Support” Contract with National Institutes of Health-Maximum Funding Potential of $102,500,000 Over Seven Years
9/15/2011 10:16:09 AM
ROCKVILLE, Md.--(BUSINESS WIRE)--The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded ABL with a contract to provide preclinical development support for promising candidates when such candidates emerge from the investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. ABL will assist NIAID staff in providing all support needed for smallscale production, preclinical testing and documentation leading to Investigational New Drug (IND) submissions for Phase I, II and III clinical testing. This work is funded in whole with federal funds from NIAID, NIH, Department of Health and Human Services, under Contract Number HHSN272201100021I.
|
|
|
|
|
|
|
|
|
|
|